Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS) | MicrobiomeTrials← Back to trialsNCT06634875
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2025-01-30Est. Completion: 2027-06-30
Enrollment target: 20 participants Locations- USC/Norris Cancer Center, Los Angeles, California, United States
- Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
- Emory University, Atlanta, Georgia, United States
Other microbiome trials you might be interested in
Colorectal NeoplasmsNeoplasmsIntrahepatic CholangiocarcinomaAdrenocortical CarcinomaMetastasis, Neoplasm
Background:
Cancers that begin in the colon, adrenal glands, or bile ducts may spread to the liver. These liver tumors …
Bethesda, United StatesEst. completion Dec 31, 2029
Colorectal NeoplasmsGastric NeoplasmsCholangiocarcinomaBile Duct CancerPancreas Cancer
Background:
\- Recent advances in cancer research have led to new therapies to treat the disease. It is important to co…
Bethesda, United StatesEst. completion Jun 30, 2035
Breast NeoplasmsColorectal NeoplasmsProstate NeoplasmEndometrial NeoplasmsNeoplasm MetastasisStomach NeoplasmsEsophageal Neoplasms
The main purpose of this study is to evaluate safety, tolerability, and efficacy of LY4257496 alone and as part of relev…
Duarte, United StatesEst. completion Apr 2030